Venmax Drugs And Pharmaceuticals12.20
+0.00 (-0.25%)

Venmax Drugs And Pharmaceuticals Share Price

12.20+0.00 (-0.25%)
-58.43% past 1 Year

Corporate filings & documents

Announcements

News paper Publication of the Unaudited Financial Results for the Quarter ended September 30 2026.
1 week ago
Statement of Deviation and Variation for the Quarter ended September 30 2026.
1 week ago
Unaudited Financial Results for the Quarter and Half Year ended September 30 206.
1 week ago
Unaudited Financial Results for the Quarter and Half Year Ended September 30 2026
1 week ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the Quarter ended September 30 2026.
2 weeks ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the Quarter ended September 30 2026.
2 weeks ago
Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24 2026.
3 weeks ago
Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24 2026.
3 weeks ago
Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24 2026.
3 weeks ago
Venmax Drugs and Pharmaceuticals Limited has informed the Bombay Stock Exchange regarding Proceedings of court convened General Meeting held today i.e. October 24 2026.
4 weeks ago
Venmax Drugs and Pharmaceuticals Limited has informed the Bombay Stock Exchange regarding Proceedings of court convened General Meeting held today i.e. October 24 2026.
4 weeks ago
Certificate under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.
1 month ago
Certificate under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026.
1 month ago
Voting Results along with the Scrutinizers Report of the 37th Annual General Meeting of the Company held on 26th September 2026 through VC/OAVM.
1 month ago
Voting Results along with the Scrutinizers Report of the 37th Annual General Meeting of the Company held on 26th September 2026 through VC/OAVM.
1 month ago
Summary of the proceedings of 37th Annual General Meeting of the shareholders held at 12.30 P.M. through video conferencing mode.
1 month ago
Summary of the proceedings of 37th Annual General Meeting of the shareholders held at 12.30 P.M. through video conferencing mode.
1 month ago
Intimation of Closure of Trading Window pursuant to declaration of Unaudited Financial Results for the quarter ended September 30 2026.
1 month ago
Intimation of Closure of Trading Window pursuant to declaration of Unaudited Financial Results for the quarter ended September 30 2026.
1 month ago
News paper Advertaisement of the meeting of Equity Share Holders Of Venmax Drugs and Pharmaceuticals Limited to be convened as per directions of Hon"ble National Company Law Tribunal (NCLT) Hyderabad Bench-II.
1 month ago
News paper Advertaisement of the meeting of Equity Share Holders Of Venmax Drugs and Pharmaceuticals Limited to be convened as per directions of Hon"ble National Company Law Tribunal (NCLT) Hyderabad Bench-II.
1 month ago
Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT Hyderabad bench II in respect of Scheme of Amalgamation of Hatri Pharma Private Limited with Venmax Drugs and Pharmaceuticals Limited.
2 months ago
Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT Hyderabad bench II in respect of Scheme of Amalgamation of Hatri Pharma Private Limited with Venmax Drugs and Pharmaceuticals Limited.
2 months ago
Venmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).
2 months ago
Venmax Drugs and Pharmaceuticals Limited has informed the exchange about the update in respect of Scheme of Amalgamation of Hatri Pharma Private Limited (Amalgamating Company) with Venmax Drugs and Pharmaceuticals Limited ( Amalgamated Company).
2 months ago
Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements) 2015.
2 months ago
Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements) 2015.
2 months ago
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 we would like to inform you that a meeting of Board of Directors of was held today i.e August 31 2026 at the registered office of the Company.
2 months ago
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 we would like to inform you that a meeting of Board of Directors of was held today i.e August 31 2026 at the registered office of the Company.
2 months ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve matters related to Annual General Meeting and any other business as the board deems fit to discuss with the permission of the chairman.
3 months ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve matters related to Annual General Meeting and any other business as the board deems fit to discuss with the permission of the chairman.
3 months ago
Newspaper Publication of the Unaudited Financial Results for the Quarter ended June 30 2026.
3 months ago
Newspaper Publication of the Unaudited Financial Results for the Quarter ended June 30 2026.
3 months ago
Statement of Deviation & Variation for the Quarter ended June 30 2026.
3 months ago
Statement of Deviation & Variation for the Quarter ended June 30 2026.
3 months ago
Unaudited Financial Results along with Limited Review Report for the Quarter ended June 30 2026.
3 months ago
Unaudited Financial Results along with Limited Review Report for the Quarter ended June 30 2026.
3 months ago
Unaudited Standalone Financial Results along with the Limited Review Report For the Quarter ended June 30 2026.
3 months ago
Unaudited Standalone Financial Results along with the Limited Review Report For the Quarter ended June 30 2026.
3 months ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited financial results for the quarter ended June 30 2026.
3 months ago
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Unaudited financial results for the quarter ended June 30 2026.
3 months ago
Allotment of 7 53 334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation 2015.
3 months ago
Allotment of 7 53 334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation 2015.
3 months ago
Allotment of 21 47 665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation 2015.
3 months ago
Allotment of 21 47 665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation 2015.
3 months ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
4 months ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
4 months ago
Intimation of Closure of Trading Window pursuant to declaration of unaudited financial results for the quarter ended June 30 2026.
4 months ago
Intimation of Closure of Trading Window pursuant to declaration of unaudited financial results for the quarter ended June 30 2026.
4 months ago
Statement of Deviation & variation for the Quarter and Year ended March 31 2026.
6 months ago

Concalls & investor presentations

Empty box

No presentations found

Venmax Drugs And Pharmaceuticals Ltd Share Price Today

The Venmax Drugs And Pharmaceuticals Ltd share price today is ₹14.5. During the trading session, the Venmax Drugs And Pharmaceuticals Ltd share price opened at ₹14.99 and recorded an intraday high of ₹15 and a low of ₹14.11. Last closing price was ₹14.81. Over the past 52 weeks, the Venmax Drugs And Pharmaceuticals Ltd share price has ranged between ₹12.71 and ₹31.49. The current Venmax Drugs And Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.